Biota Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 45   

Articles published

BOTA 2.35 +0.05 (2.17%)
price chart
Hot Stock List: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Biota ...
On 15 AUG Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) Director Alexander J. Denner acquired 850,000 shares of Ariad Pharmaceuticals stock on the open market in a transaction dated Friday. The shares were purchased at an average price of $5.83 per ...
Investor Alert:Biota Pharmaceuticals Inc (NASDAQ:BOTA) faces Investor ...
The Shareholders Foundation announces that an investigation on behalf of investors of Biota Pharmaceuticals Inc (NASDAQ:BOTA) shares was launched over potential securities laws violations by Biota Pharmaceuticals and certain of its directors and ...
Today's Stocks: Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), CTI BioPharma ...
On 4 AUG Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) said that it was graded by investment analysts at Guggenheim to a ´┐Żneutral´┐Ż rating in a note issued to investors on Monday.
Related articles »  
Today's Hot List: Splunk (NASDAQ:SPLK), Biota Pharmaceuticals (NASDAQ ...
Splunk, Inc. (NASDAQ:SPLK) announced its earnings results for the second quarter of its fiscal 2015 (2QFY15). It beat analysts' expectations on revenue and earnings, and also improved its full-year guidance.
Related articles »  
Best Stocks: Biota Pharmaceuticals (NASDAQ:BOTA), Hilton Worldwide ...
On August 1, Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) announced its experimental influenza drug failed to meet the main goal in a mid-stage study.
5 Stocks under Wall Street's Radar: ACADIA Pharmaceuticals Inc. (NASDAQ ...
On 1 AUG Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) announced top-line data from a randomized, double-blind, placebo-controlled, parallel-arm Phase 2 clinical trial comparing the safety and efficacy of a 40 mg and 80 mg dose of laninamivir octanoate ...
Related articles »  
Top News: Biota Pharmaceuticals (NASDAQ:BOTA), DryShips (NASDAQ:DRYS ...
On 19 August An investigation on behalf of investors of Biota Pharmaceuticals Inc (NASDAQ:BOTA) shares over potential securities laws violations by Biota Pharmaceuticals and certain of its directors and officers in connection certain financial ...
Today's Stocks: Biota Pharmaceuticals (NASDAQ:BOTA), Infinera Corporation ...
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) said its influenza treatment failed to meet the main goal in a mid-stage study, about two months after the company lost a key government contract supporting the drug's development.
Today's Stocks: Biota Pharmaceuticals (NASDAQ:BOTA), Alnylam ...
On August 1, 2014 Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) announced its experimental influenza drug failed to meet the main goal in a mid-stage study.
Related articles »  
Active Stocks to Watch: Alexion Pharmaceuticals (NASDAQ:ALXN), Biota ...
The CEO of Alexion Pharmaceuticals Inc (ALXN), Leonard Bell, sold more than 100,000 shares of company stock Wednesday for nearly $17 million.
Related articles »